Weekly Recap | iShares Russell 2000 -0.92%, small caps trail the S&P

LongbridgeAII'm LongbridgeAI, I can summarize articles.

iShares Russell 2000 (IWM.US) fell 0.92% this week to close at $278.94. That compares with a 1.15% gain for the S&P 500, leaving IWM.US trailing the benchmark by roughly 2.07 percentage points. The week opened with a rally attempt: the ETF touched a high of $284.64 on Monday before fading through midweek. Thursday marked the weekly low of $274.52, and Friday recovered modestly to $278.94. Average daily volume of roughly 24.8 million shares came in 17.

The Week

iShares Russell 2000 (IWM.US) fell 0.92% this week to close at $278.94. That compares with a 1.15% gain for the S&P 500, leaving IWM.US trailing the benchmark by roughly 2.07 percentage points. The week opened with a rally attempt: the ETF touched a high of $284.64 on Monday before fading through midweek. Thursday marked the weekly low of $274.52, and Friday recovered modestly to $278.94. Average daily volume of roughly 24.8 million shares came in 17.9% above the median, keeping activity elevated. Within the 60-day range, the close sits below both the 20-day moving average of $282.06 and the 60-day average of $291.61, and well off the August high of $305.18.

Sector News

Small caps faced a difficult backdrop this week, with attention split between Fed policy and valuation pressure. The September FOMC minutes showed officials unanimous on the latest hike, with several wanting to prepare for market stress. Fed Governor Waller signalled that more increases are needed but with flexibility on the pace. That narrative pushed the 10-year Treasury yield near 5.35%, weighing on longer-duration small-cap growth names. Crypto-linked equities also weakened as bitcoin slid to a two-week low, dragging on some smaller tech stocks. Insider selling stood out at the single-stock level: Twist Bioscience dropped after the CEO sold roughly $10 million of shares alongside heavy ARK unloading, while 10X Genomics slipped on a similar pattern combined with AI valuation concerns. Glaukos delivered positive Phase 3 extension data and a licensing deal, but insider sales overshadowed the news. The week’s profile for small caps was therefore one of rising rate expectations meeting concentrated selling in individual growth names.

The Week Ahead

The coming week brings a dense macro calendar with two key threads: inflation and small-business sentiment. Tuesday features the NFIB Small Business Optimism Index (prior 98.7) and annualised existing home sales (prior 3.98, forecast 3.96). Wednesday’s CPI and core CPI readings will be the central event, with multiple measures pointing to potential upside in month-over-month inflation. For a broad small-cap ETF like IWM.US, those prints will directly shape the rate path and the discount applied to valuations. The open questions left by this week’s Fed minutes and insider selling will also need confirmation from the data.

In Short

This week’s action in IWM.US set two forces against each other. The ETF sits below its 60-day moving average and near the lower end of its 60-day range, reflecting a pullback in small-cap valuations. At the same time, money flows and news flow did not offer a one-sided signal. On the latest trading day, large-lot money was a net seller while small and medium orders were net buyers, pointing to a divergence between institutions and retail. Higher rate expectations, insider selling, and crypto weakness all press on small-cap risk appetite. The key question now is whether next week’s inflation and jobs-related data can shift the rate outlook, and whether the insider-selling mood spreads beyond a handful of names into the broader small-cap complex.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.